Short Interest in Astrana Health, Inc. (NASDAQ:ASTH) Decreases By 17.9%

Astrana Health, Inc. (NASDAQ:ASTH) was the target of a significant drop in short interest in the month of November. As of November 15th, there was short interest totalling 1,560,000 shares, a drop of 17.9% from the October 31st total of 1,900,000 shares. Currently, 4.4% of the shares of the company are sold short. Based on an average trading volume of 286,600 shares, the days-to-cover ratio is presently 5.4 days.

Astrana Health Price Performance

ASTH traded up $0.39 during trading on Friday, hitting $43.25. 226,611 shares of the stock traded hands, compared to its average volume of 211,243. The business has a 50 day moving average price of $52.79 and a 200 day moving average price of $47.94. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91. Astrana Health has a twelve month low of $32.32 and a twelve month high of $63.20. The company has a market cap of $2.43 billion, a price-to-earnings ratio of 33.27, a PEG ratio of 1.99 and a beta of 1.24.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings results on Thursday, November 7th. The company reported $0.33 EPS for the quarter, hitting analysts’ consensus estimates of $0.33. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. The company had revenue of $478.71 million during the quarter, compared to analysts’ expectations of $462.01 million. During the same quarter in the previous year, the firm earned $0.47 EPS. Equities research analysts forecast that Astrana Health will post 1.17 earnings per share for the current fiscal year.

Wall Street Analysts Forecast Growth

Several analysts have weighed in on ASTH shares. Robert W. Baird lifted their price objective on shares of Astrana Health from $67.00 to $86.00 and gave the stock an “outperform” rating in a research note on Wednesday, November 13th. Truist Financial lifted their price target on shares of Astrana Health from $50.00 to $59.00 and gave the company a “buy” rating in a research report on Friday, August 9th. TD Cowen began coverage on Astrana Health in a research report on Monday, October 14th. They set a “buy” rating and a $66.00 price target on the stock. KeyCorp initiated coverage on Astrana Health in a report on Friday, October 11th. They issued a “sector weight” rating for the company. Finally, BTIG Research upped their target price on Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a research report on Thursday, October 3rd. One equities research analyst has rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat.com, Astrana Health currently has a consensus rating of “Buy” and an average price target of $65.17.

Institutional Inflows and Outflows

Several institutional investors have recently bought and sold shares of the business. State Street Corp acquired a new stake in shares of Astrana Health in the 3rd quarter valued at approximately $91,966,000. Geode Capital Management LLC acquired a new stake in Astrana Health in the third quarter valued at approximately $58,995,000. FMR LLC bought a new stake in shares of Astrana Health during the third quarter worth $48,413,000. SteelPeak Wealth LLC acquired a new position in shares of Astrana Health during the third quarter worth $39,398,000. Finally, Loomis Sayles & Co. L P bought a new position in shares of Astrana Health in the 3rd quarter valued at $30,251,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.